This opportunity is no longer accepting applications.
grant PAR-21-137

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

This grant opportunity supports early stage testing of new drug or device-based treatments for mental disorders. It emphasizes an experimental approach that not only evaluates the treatment's effects but also explores the underlying mechanisms of the disorder or response. The goal is to test treatments with novel mechanisms and understand how they work, ensuring the treatment causes specific d…

This is a reissue of RFA-MH-18-702: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required). NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in wh…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: March 2, 2021
Open for Submission: March 2, 2021
Submission Deadline: October 15, 2024
Application Window Closes: October 15, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.